Literature DB >> 29227473

Structure-inspired design of β-arrestin-biased ligands for aminergic GPCRs.

John D McCorvy1, Kyle V Butler2, Brendan Kelly3, Katie Rechsteiner1, Joel Karpiak4, Robin M Betz3, Bethany L Kormos5, Brian K Shoichet4, Ron O Dror3, Jian Jin2, Bryan L Roth1.   

Abstract

Development of biased ligands targeting G protein-coupled receptors (GPCRs) is a promising approach for current drug discovery. Although structure-based drug design of biased agonists remains challenging even with an abundance of GPCR crystal structures, we present an approach for translating GPCR structural data into β-arrestin-biased ligands for aminergic GPCRs. We identified specific amino acid-ligand contacts at transmembrane helix 5 (TM5) and extracellular loop 2 (EL2) responsible for Gi/o and β-arrestin signaling, respectively, and targeted those residues to develop biased ligands. For these ligands, we found that bias is conserved at other aminergic GPCRs that retain similar residues at TM5 and EL2. Our approach provides a template for generating arrestin-biased ligands by modifying predicted ligand interactions that block TM5 interactions and promote EL2 interactions. This strategy may facilitate the structure-guided design of arrestin-biased ligands at other GPCRs, including polypharmacological biased ligands.

Entities:  

Mesh:

Substances:

Year:  2017        PMID: 29227473      PMCID: PMC5771956          DOI: 10.1038/nchembio.2527

Source DB:  PubMed          Journal:  Nat Chem Biol        ISSN: 1552-4450            Impact factor:   15.040


  59 in total

Review 1.  How many drug targets are there?

Authors:  John P Overington; Bissan Al-Lazikani; Andrew L Hopkins
Journal:  Nat Rev Drug Discov       Date:  2006-12       Impact factor: 84.694

2.  Paramfit: automated optimization of force field parameters for molecular dynamics simulations.

Authors:  Robin M Betz; Ross C Walker
Journal:  J Comput Chem       Date:  2014-11-21       Impact factor: 3.376

3.  Comparison of the binding and functional properties of two structurally different D2 dopamine receptor subtype selective compounds.

Authors:  Robert R Luedtke; Yogesh Mishra; Qi Wang; Suzy A Griffin; Cathy Bell-Horner; Michelle Taylor; Suwanna Vangveravong; Glenn H Dillon; Ren-Qi Huang; David E Reichert; Robert H Mach
Journal:  ACS Chem Neurosci       Date:  2012-10-12       Impact factor: 4.418

Review 4.  Identifying ligand-specific signalling within biased responses: focus on δ opioid receptor ligands.

Authors:  I Charfi; N Audet; H Bagheri Tudashki; G Pineyro
Journal:  Br J Pharmacol       Date:  2014-07-01       Impact factor: 8.739

5.  Catechol-binding serines of beta(2)-adrenergic receptors control the equilibrium between active and inactive receptor states.

Authors:  C Ambrosio; P Molinari; S Cotecchia; T Costa
Journal:  Mol Pharmacol       Date:  2000-01       Impact factor: 4.436

6.  Hydrophilicity of cavities in proteins.

Authors:  L Zhang; J Hermans
Journal:  Proteins       Date:  1996-04

7.  β-arrestin-selective G protein-coupled receptor agonists engender unique biological efficacy in vivo.

Authors:  Diane Gesty-Palmer; Ling Yuan; Bronwen Martin; William H Wood; Mi-Hye Lee; Michael G Janech; Lam C Tsoi; W Jim Zheng; Louis M Luttrell; Stuart Maudsley
Journal:  Mol Endocrinol       Date:  2013-01-11

8.  Optimization of the additive CHARMM all-atom protein force field targeting improved sampling of the backbone φ, ψ and side-chain χ(1) and χ(2) dihedral angles.

Authors:  Robert B Best; Xiao Zhu; Jihyun Shim; Pedro E M Lopes; Jeetain Mittal; Michael Feig; Alexander D Mackerell
Journal:  J Chem Theory Comput       Date:  2012-07-18       Impact factor: 6.006

Review 9.  New G-protein-coupled receptor crystal structures: insights and limitations.

Authors:  Brian Kobilka; Gebhard F X Schertler
Journal:  Trends Pharmacol Sci       Date:  2008-01-14       Impact factor: 14.819

10.  Crystal structure of the β2 adrenergic receptor-Gs protein complex.

Authors:  Søren G F Rasmussen; Brian T DeVree; Yaozhong Zou; Andrew C Kruse; Ka Young Chung; Tong Sun Kobilka; Foon Sun Thian; Pil Seok Chae; Els Pardon; Diane Calinski; Jesper M Mathiesen; Syed T A Shah; Joseph A Lyons; Martin Caffrey; Samuel H Gellman; Jan Steyaert; Georgios Skiniotis; William I Weis; Roger K Sunahara; Brian K Kobilka
Journal:  Nature       Date:  2011-07-19       Impact factor: 49.962

View more
  54 in total

1.  D2 Dopamine Receptor G Protein-Biased Partial Agonists Based on Cariprazine.

Authors:  Yudao Shen; John D McCorvy; Michael L Martini; Ramona M Rodriguiz; Vladimir M Pogorelov; Karen M Ward; William C Wetsel; Jing Liu; Bryan L Roth; Jian Jin
Journal:  J Med Chem       Date:  2019-04-18       Impact factor: 7.446

Review 2.  Molecular Dynamics Simulation for All.

Authors:  Scott A Hollingsworth; Ron O Dror
Journal:  Neuron       Date:  2018-09-19       Impact factor: 17.173

Review 3.  The Opioid Crisis and the Future of Addiction and Pain Therapeutics.

Authors:  Nathan P Coussens; G Sitta Sittampalam; Samantha G Jonson; Matthew D Hall; Heather E Gorby; Amir P Tamiz; Owen B McManus; Christian C Felder; Kurt Rasmussen
Journal:  J Pharmacol Exp Ther       Date:  2019-09-03       Impact factor: 4.030

4.  Solution NMR spectroscopy of GPCRs: Residue-specific labeling strategies with a focus on 13C-methyl methionine labeling of the atypical chemokine receptor ACKR3.

Authors:  Andrew B Kleist; Francis Peterson; Robert C Tyler; Martin Gustavsson; Tracy M Handel; Brian F Volkman
Journal:  Methods Cell Biol       Date:  2018-11-15       Impact factor: 1.441

5.  Structural determinants of 5-HT2B receptor activation and biased agonism.

Authors:  John D McCorvy; Daniel Wacker; Sheng Wang; Bemnat Agegnehu; Jing Liu; Katherine Lansu; Alexandra R Tribo; Reid H J Olsen; Tao Che; Jian Jin; Bryan L Roth
Journal:  Nat Struct Mol Biol       Date:  2018-08-20       Impact factor: 15.369

Review 6.  Molecular pharmacology of metabotropic receptors targeted by neuropsychiatric drugs.

Authors:  Bryan L Roth
Journal:  Nat Struct Mol Biol       Date:  2019-07-03       Impact factor: 15.369

7.  A structural basis for how ligand binding site changes can allosterically regulate GPCR signaling and engender functional selectivity.

Authors:  Marta Sanchez-Soto; Ravi Kumar Verma; Blair K A Willette; Elizabeth C Gonye; Annah M Moore; Amy E Moritz; Comfort A Boateng; Hideaki Yano; R Benjamin Free; Lei Shi; David R Sibley
Journal:  Sci Signal       Date:  2020-02-04       Impact factor: 8.192

8.  Structure-Functional-Selectivity Relationship Studies of Novel Apomorphine Analogs to Develop D1R/D2R Biased Ligands.

Authors:  Hyejin Park; Aarti N Urs; Joseph Zimmerman; Chuan Liu; Qiu Wang; Nikhil M Urs
Journal:  ACS Med Chem Lett       Date:  2020-01-06       Impact factor: 4.345

9.  Chronic Methadone Use Alters the CD8+ T Cell Phenotype In Vivo and Modulates Its Responsiveness Ex Vivo to Opioid Receptor and TCR Stimuli.

Authors:  Claire Mazahery; Bryan L Benson; Angélica Cruz-Lebrón; Alan D Levine
Journal:  J Immunol       Date:  2020-01-22       Impact factor: 5.422

10.  Designing Functionally Selective Noncatechol Dopamine D1 Receptor Agonists with Potent In Vivo Antiparkinsonian Activity.

Authors:  Michael L Martini; Caroline Ray; Xufen Yu; Jing Liu; Vladimir M Pogorelov; William C Wetsel; Xi-Ping Huang; John D McCorvy; Marc G Caron; Jian Jin
Journal:  ACS Chem Neurosci       Date:  2019-08-20       Impact factor: 4.418

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.